Recent press releases

December 22, 2016

HAEA showcased at a national Research Community Forum

November 14, 2016

Pharming announces the presentation of the results of the RUCONEST® Phase II study for prophylaxis of Hereditary Angioedema attacks

August 30, 2016

FDA Accepts CSL Behring’s Biologics License Application for First Subcutaneous Prophylactic Therapy to Prevent Hereditary Angioedema Attacks

July 18, 2016

U.S. FDA Approves CSL Behring’s Berinert® as the First and Only Pediatric Treatment for Hereditary Angioedema (HAE)

WHO WE ARE

The US HAEA is a non-profit patient advocacy organization dedicated to serving persons with angioedema.
We provide patients and families with a support network and wide range of services.

WE ARE
  • PATIENTS
  • CAREGIVERS
  • UNBIASED
  • RELIABLE
  • HERE FOR YOU
  • HAE.

Press contact


Janet Long
Executive Vice President
Contact Janet Long

HAEA on social media

                  

Post your HAE related content with our shared tags
#haea
#wearehae
#raredisease

Download

 

Jump to our sections with comprehensive content and learn more

null

What is HAE

Get to know the disease: symptoms, diagnose, treatments and more

Take me there >

Professionals

For healthcare providers. Knowledge, CME-programs and more

Take me there >

Living with HAE

Care takers and givers: HAE will affect your life - But you can still be in control.

Take me there >

Resources

Our area with a lot of usefull information

Take me there >